Page 5 - Sohini Das

India Inc looks to plug into EV-charging infrastructure at work

Firms offering such vehicles as car lease options, converting their fleet into EVs

Remembering BV Doshi, the great architect who strived to build timelessness

Pritzker awardee, Doshi blended modernist values with local ethos; the IIM-B building is an example

DRL posts strong 77% profit growth to Rs 1,247 cr riding on US, Russia

Firm says sustained focus on improving productivity has also helped boost profits; DRL is now bullish on its biosimilars and hopes to start filing for them in US in the coming quarters

Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US

Revenue up 6% to Rs 5,810 cr; firm expects US FDA audit at Goa unit

Dialysis business in growth mode amid rising treatment demand in India

The industry estimates that there are some 20 million patients with chronic kidney disease in India, but only 20 per cent get dialysis treatment

Lupin Digital launches Lyfe, a 24x7 monitoring ecosystem for heart patients

Company aims to onboard one million patients the platform, which aims to help them improve heart health through doctor-connected online and offline modules

Bharat Biotech starts voluntary recall of rabies vaccine after batch theft

Company had tested the batch and released it, but part of it was stolen, for which cold chain storage integrity was unknown. Decision made to recall the entire batch

Hero Electric looks to raise nearly Rs 2,000 crore to drive expansion

The company is not looking for mergers and acquisitions, but is open to having a strategic investor who can bring some technical expertise

Bajaj Auto's electric Chetak to roll out in Europe by early 2024

Company's Chakan plant has just produced its 1 millionth KTM bike

Sun Pharma to acquire US-based Concert Pharmaceuticals for $576 million

Deal size could expand to $827 mn if additional milestone-based payments are made

Pharma, healthcare Q3FY23 preview: Cost pressures abating to aid margins

Hospitals are expected to report a soft Q3 result due to a mix of seasonality and easing pent-up demand, however, average revenue per occupied bed is likely to remain steady

Cipla launches diagnostic device, says it will provide results in minutes

Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility

Indian consumers concerned about residual value of EV battery: Survey

Public opinion growing in favour of EV as consumers want to save money on fuel: Deloitte

Covid-19: Serum's Covovax gets the nod as a mix-and-match booster shot

Experts say no current vaccine protects against sub-lineages of Omicron

Glenmark pharma launches generic version of Novartis' heart failure drug

Opens floodgates for more generic launches; 40 new brands expected

Ceat is planning to invest in off-highway tyres segment: Anant Goenka

At Ceat we wanted to grow in our international business, and our OEM customers were becoming more and more exacting in their specifications, said Goenka

Drivers of change: More women buy luxury cars in post-pandemic shift

Audi India has registered a 27 percent growth compared to the last year selling 4187 retail units in 2022

Breather for Natco in Novartis cardiac drug case from Delhi High Court

May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week

At 3.8 million units, PV sales rev up to highest ever in 2022: Siam

Data showed that passenger vehicle sales grew by 23 per cent in 2022 compared to the previous year to touch 3.79 million units

Roadblocks on exit route: GM, Ford struggle with lingering staff problems

The two Detroit majors are struggling with lingering employee problems as they seek to drive out of the Indian market